Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's New Enforcement Approach Will Put More Warning Letters In The Mail

This article was originally published in The Gray Sheet

Executive Summary

FDA Commissioner Margaret Hamburg is honing the agency's enforcement system to get warning letters out faster and create a formal "close-out" process that publicly indicates when a firm has addressed FDA's concerns

You may also be interested in...



Jury Still Out On Success Of FDA's Warning Letter Close-Out Program

FDA is extending its warning letter "close-out" pilot program to learn more about its value, even as grumblings begin that the program may not be all it was cracked up to be.

Jury Still Out On Success Of FDA's Warning Letter Close-Out Program

FDA is extending its warning letter "close-out" pilot program to learn more about its value, even as grumblings begin that the program may not be all it was cracked up to be.

FDA Seeks To Speed Seizure, Injunction Decisions With More Collaboration

FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.

Related Content

Topics

UsernamePublicRestriction

Register

LL018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel